| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |